| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/07/1999 | EP0906086A1 Composition |
| 04/07/1999 | EP0906071A1 Apparatus and method of delivery of gas-supersaturated liquids |
| 04/07/1999 | EP0810855A4 Polyalkylene block copolymers as surface modifiers for nanoparticles |
| 04/07/1999 | EP0764020B1 Transdermal drug delivery system |
| 04/07/1999 | EP0742715B1 Oral liquid compositions containing paroxetine resinate |
| 04/07/1999 | EP0656883B1 Cationic lipids |
| 04/07/1999 | EP0538313B1 Topical ophthalmic suspensions |
| 04/07/1999 | CN1213316A Polymeric delivery of radionuclides and radiopharmaceuticals |
| 04/07/1999 | CN1213314A Improved vision through photodynamic therapy of eye |
| 04/07/1999 | CN1213301A Sustained-release metal valproate tablets |
| 04/07/1999 | CN1213299A Solid formulations containing trehalose |
| 04/07/1999 | CN1213298A 附聚物 Agglomerates |
| 04/07/1999 | CN1213295A Aqueous product comprising oil microdroplets stabilized by in-situ polymerized binyl monomer and thickening agent |
| 04/07/1999 | CN1213292A Hair conditioning compositions |
| 04/07/1999 | CN1213282A Oral peptide pharmaceutical products |
| 04/07/1999 | CN1212890A Compositions useful for transferring therapeutically active substances into target cell, and their use in gene therapy |
| 04/07/1999 | CN1212885A Traditional Chinese medicine capsule for treating thrombophlebitis |
| 04/07/1999 | CN1212881A Method for preparing fermented soya beans and ginger injecta |
| 04/07/1999 | CN1212874A 'Futekang' traditional Chinese medicine emulsion and preparation method thereof |
| 04/07/1999 | CN1212869A Fixed-dose association of angiotensin-converting enzyme inhibitor and of calcium channel antagonist, method for preparation and use thereof in treatment of cardivas cular illnesses |
| 04/07/1999 | CN1212866A Method for manufacturing skin beautiful emulsifiable paste |
| 04/07/1999 | CN1042799C Analgetic plaster for promoting blood circulation and removing blood stasis |
| 04/07/1999 | CN1042794C Improved emulsions of highly fluorinated organic compounds |
| 04/06/1999 | US5892071 Cationic transport reagents |
| 04/06/1999 | US5892026 Supersaturated composition prepared by dissolving syrup at ambient temperature with one or more saccharides as crystal growth inhibitors in equal or greater amount; uncontaminated with bacteria; for foods, feeds, drugs, cosmetics |
| 04/06/1999 | US5891920 Medicinal adjuvants consisting of N-subsitituted-o-toluidine derivatives, and percutaneously absorbable preparations comprising the adjuvants |
| 04/06/1999 | US5891907 Stable aqueous solubilizates of carotenoids and vitamins |
| 04/06/1999 | US5891868 Methods for treating postmenopausal women using ultra-low doses of estrogen |
| 04/06/1999 | US5891867 Hormonal medicaments and their use for the correction of oestrogenic deficiencies |
| 04/06/1999 | US5891845 Drug delivery systems utilizing liquid crystal structures |
| 04/06/1999 | US5891801 Palatable liquid-admininstered oral medicaments for relief of discomfort and flavoring combinations therefor |
| 04/06/1999 | US5891714 Liposome-antisense oligonucleotide aggregate |
| 04/06/1999 | US5891478 Composition for sustained release of human growth hormone |
| 04/06/1999 | US5891477 Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device |
| 04/06/1999 | US5891476 Drug core with wax coating |
| 04/06/1999 | US5891475 Non-liquid hydrophilic core, an external layer comprised of lipid compounds grafted on the core by covalent bonds. enhancing the activity of the polypeptide cellular mediator. |
| 04/06/1999 | US5891474 Administering a pharmaceutical formulation comprising a core including the pharmaceutically active agent to be delivered, and a swellable polymeric coating layer substantially surrounding the core |
| 04/06/1999 | US5891473 Toothpastes |
| 04/06/1999 | US5891472 Topical treatment for administering nitric oxide in lipid based carriers |
| 04/06/1999 | US5891471 Mechanically working a mixture of a drug and a hydrophobic and/or hydrophilic fusible carrier in a high speed mixture so as to form agglomerates and breaking the agglomerates to give controlled release particles. |
| 04/06/1999 | US5891470 Softgel formulation containing retinol |
| 04/06/1999 | US5891469 Improved oral delivery and enhanced bioavailability of lipophilic substances using compositions containing tocopherol polyethylene glycol succinate |
| 04/06/1999 | US5891468 Fusogenic liposome compositions and method |
| 04/06/1999 | US5891467 Encapsulation and release of active compounds |
| 04/06/1999 | US5891466 Fatty acid, monoglyceride, lysophosphatidyl choline, bicarbonate |
| 04/06/1999 | US5891465 Delivery of biologically active material in a liposomal formulation for administration into the mouth |
| 04/06/1999 | US5891464 Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it |
| 04/06/1999 | US5891463 Nonocclusive drug delivery device and process for its manufacture |
| 04/06/1999 | US5891462 Composition for transdermal administration of an estrogen |
| 04/06/1999 | US5891461 Treating psychosis, acute mania or anxiety by applying a transdermal patch to intact skin or mucosal tissue, administering olanzapine or its acid addition salts, and a skin permeation enhancer |
| 04/06/1999 | US5891460 Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof |
| 04/06/1999 | US5891458 Lyophilized foam, sustained and controlled release |
| 04/06/1999 | US5891457 Treating menorrhagia with silver nitrate composition |
| 04/06/1999 | US5891456 Glyceryl monosterate based biodegradable implants for site-specific delivery of drugs |
| 04/06/1999 | US5891454 Anti-cancer drug and special tumor necrotizing agent |
| 04/06/1999 | US5891448 Two-component fluoride delivery system, enhanced fluoride deposition in the oral environment. |
| 04/06/1999 | US5891428 Physically active antimicrobial gel for cosmetic products |
| 04/06/1999 | US5891420 Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation |
| 04/06/1999 | US5891419 Environmentally safe flunisolide aerosol formulations for oral inhalation |
| 04/06/1999 | US5891341 Compositions and devices for partitioning advanced glycosylation endproducts, and methods of their use |
| 04/06/1999 | CA2248838A1 An intravenous form of thalidomide for the therapy of immunological diseases |
| 04/06/1999 | CA2155005C Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant |
| 04/06/1999 | CA2146192C Polyionic insoluble hydrogels comprising xanthan |
| 04/06/1999 | CA2140255C Polyarylates containing derivatives of the natural amino acid l-tyrosine |
| 04/06/1999 | CA2074320C Process for the preparation of microspheres made of a biodegradable polymeric material |
| 04/06/1999 | CA2064190C Process for preparation of an oil in water emulsion of a drug |
| 04/06/1999 | CA2061824C Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| 04/06/1999 | CA2050045C Pharmaceutical, vaginal applicable preparation and a process for its preparation |
| 04/06/1999 | CA2019117C Aqueous dispersions of polyester and polyesteramides cross-linked with metallic ions and casts made therefrom |
| 04/06/1999 | CA1340487C Ph-neutral aqueous solutions of quinolone-carboxylic acids |
| 04/01/1999 | WO1999015703A1 Inhibition of an fgf-binding protein using ribozymes |
| 04/01/1999 | WO1999015637A1 Fibrin microbeads and uses thereof |
| 04/01/1999 | WO1999015628A1 Methods and compositions for binding hematopoietic stem cells |
| 04/01/1999 | WO1999015528A1 Acidic addition salts of morphine alkaloids and the application thereof |
| 04/01/1999 | WO1999015501A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents |
| 04/01/1999 | WO1999015210A2 Bioadhesive compositions and methods for topical administration of active agents |
| 04/01/1999 | WO1999015206A1 Methods for preparing lipids/polynucleotide transfection complexes |
| 04/01/1999 | WO1999015203A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
| 04/01/1999 | WO1999015193A1 LIQUID INTERFERON-β FORMULATIONS |
| 04/01/1999 | WO1999015182A1 New use for budesonide and formoterol |
| 04/01/1999 | WO1999015180A1 Coated dosage units |
| 04/01/1999 | WO1999015172A1 Medicament formulation with a controlled release of an active agent |
| 04/01/1999 | WO1999015171A1 Nicotine compositions and methods of formulation thereof |
| 04/01/1999 | WO1999015166A1 Parasiticidal formulations |
| 04/01/1999 | WO1999015165A1 Topical non-steroidal anti-inflammatory drug composition |
| 04/01/1999 | WO1999015156A1 Inhibition of crystallization in transdermal devices |
| 04/01/1999 | WO1999015155A1 Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| 04/01/1999 | WO1999015154A1 Methods for fabricating polymer-based controlled release preparations |
| 04/01/1999 | WO1999015153A1 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 04/01/1999 | WO1999015152A1 Medical emulsion lubricant |
| 04/01/1999 | WO1999015151A1 Acoustically activated localized drug delivery |
| 04/01/1999 | WO1999015150A1 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 04/01/1999 | WO1999015035A1 Smoking products containing antioxidants |
| 04/01/1999 | WO1999002186A3 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 04/01/1999 | WO1999002182A3 Non-aqueous vaccines |
| 04/01/1999 | WO1999002133A3 Topical application of a combination of benzoyl peroxide and a second active ingredient |
| 04/01/1999 | WO1999002131A3 Microparticles based on hybrid polymeric materials for controlled release of biologically active molecules, a process for preparing the same and their uses for in vivo and in vitro therapy, prophylaxis and diagnostics |
| 04/01/1999 | WO1998056370A3 Therapeutic nanospheres |
| 04/01/1999 | WO1998047485A3 Apatite-coated solid composition |
| 04/01/1999 | DE19743323A1 Solid selegiline dosage form |